Walid Abi-Saab
Chief Tech/Sci/R&D Officer en UNIQURE N.V. .
Fortuna: 606 840 $ al 31/03/2024
Perfil
El Dr. Walid Abi-Saab, MD, es Director Médico de Galapagos NV. Anteriormente, el Dr. Abi-Saab trabajó como Vicepresidente del Grupo de Desarrollo Clínico en Shire Plc y como Profesor Adjunto de Psiquiatría y Neurocirugía en la Facultad de Medicina de Yale. Se doctoró en la Universidad de Saint Joseph (Macao).
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
UNIQURE N.V.
0.24% | 01/03/2024 | 116 700 ( 0.24% ) | 606 840 $ | 31/03/2024 |
Cargos activos de Walid Abi-Saab
| Empresas | Cargo | Inicio |
|---|---|---|
| UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 26/06/2023 |
Antiguos cargos conocidos de Walid Abi-Saab.
| Empresas | Cargo | Fin |
|---|---|---|
| GALAPAGOS NV | Chief Tech/Sci/R&D Officer | 31/12/2022 |
Shire International GmbH (Switzerland)
 Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
| Yale School of Medicine | Corporate Officer/Principal | - |
Formación de Walid Abi-Saab.
| American University of Beirut | Undergraduate Degree |
| Université Saint-Joseph | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| UNIQURE N.V. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Health Technology |
- Bolsa de valores
- Insiders
- Walid Abi-Saab
